Cargando…
Mac-2 binding protein glycosylation isomer, the FIB-4 index, and a combination of the two as predictors of non-alcoholic steatohepatitis
Approximately 10% non-alcoholic fatty liver disease (NAFLD) cases progress to non-alcoholic steatohepatitis (NASH). Liver biopsy, the gold standard for diagnosing NASH and associated liver fibrosis, is invasive with a risk of life-threatening complications. Therefore, reliable non-invasive biomarker...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648718/ https://www.ncbi.nlm.nih.gov/pubmed/36355761 http://dx.doi.org/10.1371/journal.pone.0277380 |
_version_ | 1784827637400600576 |
---|---|
author | Kiyoaki, Ito Sumida, Yoshio Nakade, Yukiomi Okumura, Akinori Nishimura, Sayaka Ibusuki, Mayu Kitano, Rena Sakamoto, Kazumasa Kimoto, Satoshi Inoue, Tadahisa Kobayashi, Yuji Fukuzawa, Yoshitaka Yoneda, Masashi |
author_facet | Kiyoaki, Ito Sumida, Yoshio Nakade, Yukiomi Okumura, Akinori Nishimura, Sayaka Ibusuki, Mayu Kitano, Rena Sakamoto, Kazumasa Kimoto, Satoshi Inoue, Tadahisa Kobayashi, Yuji Fukuzawa, Yoshitaka Yoneda, Masashi |
author_sort | Kiyoaki, Ito |
collection | PubMed |
description | Approximately 10% non-alcoholic fatty liver disease (NAFLD) cases progress to non-alcoholic steatohepatitis (NASH). Liver biopsy, the gold standard for diagnosing NASH and associated liver fibrosis, is invasive with a risk of life-threatening complications. Therefore, reliable non-invasive biomarkers for predicting NASH are required to prevent unnecessary liver biopsies. We evaluated the performance of two non-invasive fibrosis markers, Mac-2 binding protein glycosylation isomer (M2BPGi) and the FIB-4 index for predicting the fibrosis staging, NAFLD activity scoring (NAS) index, and NASH. We also analyzed the correlation between the two markers. The sensitivities, specificities, positive predictive values (PPV), and negative predictive values of the FIB-4 index, M2BPGi, and a combination of both markers for NASH diagnosis were evaluated. The M2BPGi and FIB-4 index showed a good performance in diagnosing NASH, the fibrosis stage, and the NAS index in NAFLD patients. While both markers were well-correlated with each other in most cases, no correlation was found in some patients. Compared with the FIB-4 index or the M2BPGi alone, a combination of the two showed a higher specificity, PPV, and accuracy for NASH diagnosis. The M2BPGi and the FIB-4 index are easily accessible and reliable liver fibrosis markers. Diseases other than liver disease may cause dissociation between the two markers, causing failure to predict NASH. However, the combination of both markers can compensate for their disadvantages. Because the PPV of the combination was relatively high, patients who test positive for both markers should undergo liver biopsy for NASH diagnosis. |
format | Online Article Text |
id | pubmed-9648718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-96487182022-11-15 Mac-2 binding protein glycosylation isomer, the FIB-4 index, and a combination of the two as predictors of non-alcoholic steatohepatitis Kiyoaki, Ito Sumida, Yoshio Nakade, Yukiomi Okumura, Akinori Nishimura, Sayaka Ibusuki, Mayu Kitano, Rena Sakamoto, Kazumasa Kimoto, Satoshi Inoue, Tadahisa Kobayashi, Yuji Fukuzawa, Yoshitaka Yoneda, Masashi PLoS One Research Article Approximately 10% non-alcoholic fatty liver disease (NAFLD) cases progress to non-alcoholic steatohepatitis (NASH). Liver biopsy, the gold standard for diagnosing NASH and associated liver fibrosis, is invasive with a risk of life-threatening complications. Therefore, reliable non-invasive biomarkers for predicting NASH are required to prevent unnecessary liver biopsies. We evaluated the performance of two non-invasive fibrosis markers, Mac-2 binding protein glycosylation isomer (M2BPGi) and the FIB-4 index for predicting the fibrosis staging, NAFLD activity scoring (NAS) index, and NASH. We also analyzed the correlation between the two markers. The sensitivities, specificities, positive predictive values (PPV), and negative predictive values of the FIB-4 index, M2BPGi, and a combination of both markers for NASH diagnosis were evaluated. The M2BPGi and FIB-4 index showed a good performance in diagnosing NASH, the fibrosis stage, and the NAS index in NAFLD patients. While both markers were well-correlated with each other in most cases, no correlation was found in some patients. Compared with the FIB-4 index or the M2BPGi alone, a combination of the two showed a higher specificity, PPV, and accuracy for NASH diagnosis. The M2BPGi and the FIB-4 index are easily accessible and reliable liver fibrosis markers. Diseases other than liver disease may cause dissociation between the two markers, causing failure to predict NASH. However, the combination of both markers can compensate for their disadvantages. Because the PPV of the combination was relatively high, patients who test positive for both markers should undergo liver biopsy for NASH diagnosis. Public Library of Science 2022-11-10 /pmc/articles/PMC9648718/ /pubmed/36355761 http://dx.doi.org/10.1371/journal.pone.0277380 Text en © 2022 Kiyoaki et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Kiyoaki, Ito Sumida, Yoshio Nakade, Yukiomi Okumura, Akinori Nishimura, Sayaka Ibusuki, Mayu Kitano, Rena Sakamoto, Kazumasa Kimoto, Satoshi Inoue, Tadahisa Kobayashi, Yuji Fukuzawa, Yoshitaka Yoneda, Masashi Mac-2 binding protein glycosylation isomer, the FIB-4 index, and a combination of the two as predictors of non-alcoholic steatohepatitis |
title | Mac-2 binding protein glycosylation isomer, the FIB-4 index, and a combination of the two as predictors of non-alcoholic steatohepatitis |
title_full | Mac-2 binding protein glycosylation isomer, the FIB-4 index, and a combination of the two as predictors of non-alcoholic steatohepatitis |
title_fullStr | Mac-2 binding protein glycosylation isomer, the FIB-4 index, and a combination of the two as predictors of non-alcoholic steatohepatitis |
title_full_unstemmed | Mac-2 binding protein glycosylation isomer, the FIB-4 index, and a combination of the two as predictors of non-alcoholic steatohepatitis |
title_short | Mac-2 binding protein glycosylation isomer, the FIB-4 index, and a combination of the two as predictors of non-alcoholic steatohepatitis |
title_sort | mac-2 binding protein glycosylation isomer, the fib-4 index, and a combination of the two as predictors of non-alcoholic steatohepatitis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648718/ https://www.ncbi.nlm.nih.gov/pubmed/36355761 http://dx.doi.org/10.1371/journal.pone.0277380 |
work_keys_str_mv | AT kiyoakiito mac2bindingproteinglycosylationisomerthefib4indexandacombinationofthetwoaspredictorsofnonalcoholicsteatohepatitis AT sumidayoshio mac2bindingproteinglycosylationisomerthefib4indexandacombinationofthetwoaspredictorsofnonalcoholicsteatohepatitis AT nakadeyukiomi mac2bindingproteinglycosylationisomerthefib4indexandacombinationofthetwoaspredictorsofnonalcoholicsteatohepatitis AT okumuraakinori mac2bindingproteinglycosylationisomerthefib4indexandacombinationofthetwoaspredictorsofnonalcoholicsteatohepatitis AT nishimurasayaka mac2bindingproteinglycosylationisomerthefib4indexandacombinationofthetwoaspredictorsofnonalcoholicsteatohepatitis AT ibusukimayu mac2bindingproteinglycosylationisomerthefib4indexandacombinationofthetwoaspredictorsofnonalcoholicsteatohepatitis AT kitanorena mac2bindingproteinglycosylationisomerthefib4indexandacombinationofthetwoaspredictorsofnonalcoholicsteatohepatitis AT sakamotokazumasa mac2bindingproteinglycosylationisomerthefib4indexandacombinationofthetwoaspredictorsofnonalcoholicsteatohepatitis AT kimotosatoshi mac2bindingproteinglycosylationisomerthefib4indexandacombinationofthetwoaspredictorsofnonalcoholicsteatohepatitis AT inouetadahisa mac2bindingproteinglycosylationisomerthefib4indexandacombinationofthetwoaspredictorsofnonalcoholicsteatohepatitis AT kobayashiyuji mac2bindingproteinglycosylationisomerthefib4indexandacombinationofthetwoaspredictorsofnonalcoholicsteatohepatitis AT fukuzawayoshitaka mac2bindingproteinglycosylationisomerthefib4indexandacombinationofthetwoaspredictorsofnonalcoholicsteatohepatitis AT yonedamasashi mac2bindingproteinglycosylationisomerthefib4indexandacombinationofthetwoaspredictorsofnonalcoholicsteatohepatitis |